Chemical synthesis and peptide ligation techniques have revolutionised the field of protein engineering by enabling the precise construction of peptides and proteins with tailored modifications. These ...

Amide Technologies has raised $16.5 million in venture capital to help commercialize its peptide production process. The process was developed from 2011 to 2017 in the lab of the Massachusetts ...

Peptide therapeutics have progressed from insulin discovery to GLP-1 class molecules, revolutionizing diabetes treatment and ...

The two companies enter into a multi-year strategic agreement to accelerate drug development timelines, strengthen U.S. manufacturing capabilities and help bring lifesaving medicines to patients ...

Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have addressed a long-standing challenge in the pharmaceutical industry, with the development of a two-step, one-pot method for ...

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat ...

Therapeutic peptides constitute an unusual drug category. Although most therapeutic peptides are synthetic, their molecular weights are well above those of small-molecule drugs, but well below those ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amide Technologies, a leading biotech company specializing in the synthesis of complex peptides, announced today the appointment of Dr. Brad Pentelute as its new CEO ...

Chromatography industry faces AI adoption challenges, workforce issues, and budget constraints, with biopharmaceutical sectors showing career growth. Peptide science is revolutionized by GLP-1 drugs, ...

Dublin, May 28, 2020 (GLOBE NEWSWIRE) -- The "Global Peptide Synthesis Market By Application (Epitope-specific antibodies, Epitope mapping, Others), By Type, By Technology, By Product, By Type of ...